Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals.
Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals.
Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals.
The effect of cell subset isolation method on gene expression in leukocytes.
Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection.
Attacking the HIV reservoir from the immune and viral perspective.
Child cured of HIV: can this be repeated?
Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.
HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein.
Learning from drug changes in antiretroviral therapy.